<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35573651</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>19</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Print">2352-9067</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>40</Volume>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>International journal of cardiology. Heart &amp; vasculature</Title>
          <ISOAbbreviation>Int J Cardiol Heart Vasc</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Long-term health outcomes in young adults after Kawasaki disease.</ArticleTitle>
        <Pagination>
          <StartPage>101039</StartPage>
          <MedlinePgn>101039</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">101039</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijcha.2022.101039</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">We compared the long-term health of adults with prior Kawasaki disease (KD) to controls and determined whether outcomes varied by coronary artery (CA) status.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We conducted a prospective cohort study of 258 KD subjects (mean 19 ± 9 years since KD) and 148 age-similar controls who completed extensive health questionnaires. KD subjects were divided into 2 groups, Cohort 1: 109 subjects followed since KD diagnosis at our institution; Cohort 2: 149 KD subjects diagnosed elsewhere.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">KD subjects and controls were of similar age at the time of questionnaire completion (p = 0.50). Overall, 128 subjects (including 60 in Cohort 1) reported normal CAs during and after KD. Compared to controls, KD subjects with normal CAs reported several medical conditions with increased prevalence including migraine headaches, shortness of breath, and leg pain with walking, among others. When limited to Cohort 1, KD subjects were significantly more likely to report chest pain (47% vs 16%, p &lt; 0.001) or palpitations (23% vs 10%, p = 0.01) compared to controls. Prevalence of depression was similar (7% vs 5%, p = 0.73).</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Despite always having normal CAs in the acute and subacute phases of KD, young adults with a history of KD with normal coronaries were more likely than controls to experience cardiovascular symptoms. These differences could be influenced by anxiety or depression, but report of depression was similar between groups. Whether these health differences reflect a heightened awareness of symptoms among KD subjects, or underlying vascular pathology (i.e. vasospasm, microvascular dysfunction, other) merits further study.</AbstractText>
          <CopyrightInformation>© 2022 The Author(s).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Daniels</LastName>
            <ForeName>Lori B</ForeName>
            <Initials>LB</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Cardiovascular Medicine, University of California San Diego, La Jolla, CA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Roberts</LastName>
            <ForeName>Samantha</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, University of California San Diego, La Jolla, CA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Moreno</LastName>
            <ForeName>Elizabeth</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, University of California San Diego, La Jolla, CA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tremoulet</LastName>
            <ForeName>Adriana H</ForeName>
            <Initials>AH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, University of California San Diego, La Jolla, CA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gordon</LastName>
            <ForeName>John B</ForeName>
            <Initials>JB</Initials>
            <AffiliationInfo>
              <Affiliation>San Diego Cardiac Center and Sharp Memorial Hospital, San Diego, CA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Burns</LastName>
            <ForeName>Jane C</ForeName>
            <Initials>JC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, University of California San Diego, La Jolla, CA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>04</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Int J Cardiol Heart Vasc</MedlineTA>
        <NlmUniqueID>101649525</NlmUniqueID>
        <ISSNLinking>2352-9067</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Coronary artery aneurysms</Keyword>
        <Keyword MajorTopicYN="N">Kawasaki disease</Keyword>
        <Keyword MajorTopicYN="N">Microvascular dysfunction</Keyword>
        <Keyword MajorTopicYN="N">Migraine</Keyword>
        <Keyword MajorTopicYN="N">Vasospasm</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>16</Day>
          <Hour>4</Hour>
          <Minute>30</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35573651</ArticleId>
        <ArticleId IdType="pmc">PMC9096130</ArticleId>
        <ArticleId IdType="doi">10.1016/j.ijcha.2022.101039</ArticleId>
        <ArticleId IdType="pii">S2352-9067(22)00088-4</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Newburger J.W., Takahashi M., Burns J.C., Beiser A.S., Chung K.J., Duffy C.E., Glode M.P., Mason W.H., Reddy V., Sanders S.P., Shulman S.T., Wiggins J.W., Hicks R.V., Fulton D.R., Lewis A.B., Leung D.Y.M., Colton T., Rosen F.S., Melish M.E. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl. J. Med. 1986;315(6):341–347.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2426590</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Selamet Tierney E.S., Gal D., Gauvreau K., Baker A.L., Trevey S., O'Neill S.R., Jaff M.R., de Ferranti S., Fulton D.R., Colan S.D., Newburger J.W. Vascular health in Kawasaki disease. J. Am. Coll. Cardiol. 2013;62(12):1114–1121.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23835006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McCrindle B.W., Manlhiot C., Newburger J.W., Harahsheh A.S., Giglia T.M., Dallaire F., et al.  Medium-term complications associated with coronary artery aneurysms after Kawasaki disease: a study from the International Kawasaki Disease Registry. J. Am. Heart Assoc. 2020;9</Citation>
        </Reference>
        <Reference>
          <Citation>Tsuda E., Hamaoka K., Suzuki H., Sakazaki H., Murakami Y., Nakagawa M., Takasugi H., Yoshibayashi M. A survey of the 3-decade outcome for patients with giant aneurysms caused by Kawasaki disease. Am. Heart J. 2014;167(2):249–258.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24439987</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tsuda E., Hirata T., Matsuo O., Abe T., Sugiyama H., Yamada O. The 30-year outcome for patients after myocardial infarction due to coronary artery lesions caused by Kawasaki disease. Pediatr. Cardiol. 2011;32(2):176–182.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21120463</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kato H., Sugimura T., Akagi T., Sato N., Hashino K., Maeno Y., Kazue T., Eto G., Yamakawa R. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation. 1996;94(6):1379–1385.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8822996</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kahn A.M., Budoff M.J., Daniels L.B., Oyamada J., Gordon J.B., Burns J.C. Usefulness of calcium scoring as a screening examination in patients with a history of Kawasaki Disease. Am. J. Cardiol. 2017;119(7):967–971.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5348258</ArticleId>
            <ArticleId IdType="pubmed">28193446</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McCrindle B.W., Rowley A.H., Newburger J.W., Burns J.C., Bolger A.F., Gewitz M., Baker A.L., Jackson M.A., Takahashi M., Shah P.B., Kobayashi T., Wu M.-H., Saji T.T., Pahl E. Diagnosis, treatment, and long-term management of Kawasaki Disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135(17) doi: 10.1161/CIR.0000000000000484.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIR.0000000000000484</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheung Y.-f., Wong S.J., Ho M.H.K. Relationship between carotid intima-media thickness and arterial stiffness in children after Kawasaki disease. Arch. Dis. Child. 2007;92(1):43–47.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2083125</ArticleId>
            <ArticleId IdType="pubmed">16820386</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dhillon R., Clarkson P., Donald A.E., Powe A.J., Nash M., Novelli V., Dillon M.J., Deanfield J.E. Endothelial dysfunction late after Kawasaki disease. Circulation. 1996;94(9):2103–2106.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8901658</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dalla Pozza R., Bechtold S., Urschel S., Kozlik-Feldmann R., Netz H. Subclinical atherosclerosis, but normal autonomic function after Kawasaki disease. J. Pediatr. 2007;151(3):239–243.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17719930</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kadono T., Sugiyama H., Hoshiai M., Osada M., Tan T., Naitoh A., Watanabe M., Koizumi K., Nakazawa S. Endothelial function evaluated by flow-mediated dilatation in pediatric vascular disease. Pediatr. Cardiol. 2005;26(4):385–390.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15633046</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gupta-Malhotra M., Gruber D., Abraham S.S., Roman M.J., Zabriskie J.B., Hudgins L.C., Flynn P.A., Levine D.M., Okorie U., Baday A., Schiller M.S., Maturi J., Meehan D., Dyme J., Parker T.S., Wittkowski K.M., Gersony W.M., Cooper R.S. Atherosclerosis in survivors of Kawasaki disease. J. Pediatr. 2009;155(4):572–577.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19595365</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dietz S.M., Tacke C.E., Hutten B.A., Kuijpers T.W. Peripheral endothelial (dys)function, arterial stiffness and carotid intima-media thickness in patients after Kawasaki disease: a systematic review and meta-analyses. PLoS One. 2015;10 doi: 10.1371/journal.pone.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>K. Holland, E. Riley, The ADD resource center, 2014.</Citation>
        </Reference>
        <Reference>
          <Citation>Kuo H.-C., Chang W.-C., Wang L.-J., Li S.-C., Chang W.-P. Association of attention deficit hyperactivity disorder and Kawasaki disease: a nationwide population-based cohort study. Epidemiol. Psychiatr. Sci. 2016;25(6):573–580.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7137668</ArticleId>
            <ArticleId IdType="pubmed">26392050</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin C.H., Lin W.D., Chou I.C., Lee I.C., Hong S.Y. Heterogeneous neurodevelopmental disorders in children with Kawasaki disease: what is new today? BMC Pediatr. 2019;19:406.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6827201</ArticleId>
            <ArticleId IdType="pubmed">31684911</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen M.-H., Su T.-P., Chen Y.-S., Hsu J.-W., Huang K.-L., Chang W.-H., Chen T.-J., Bai Y.-M. Comorbidity of allergic and autoimmune diseases among patients with ADHD. J. Atten. Disord. 2017;21(3):219–227.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23400216</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuo H.-C., Chang W.-C., Yang K.D., Yu H.-R., Wang C.-L., Ho S.-C., Yang C.-Y. Kawasaki disease and subsequent risk of allergic diseases: a population-based matched cohort study. BMC Pediatr. 2013;13(1) doi: 10.1186/1471-2431-13-38.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2431-13-38</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Woon P.Y., Chang W.C., Liang C.-C., Hsu C.H., Klahan S., Huang Y.-H., Chang W.-P., Kuo H.-C. Increased risk of atopic dermatitis in preschool children with Kawasaki disease: a population-based study in Taiwan. Evid. Based Complement Alternat. Med. 2013;2013:1–7.</Citation>
        </Reference>
        <Reference>
          <Citation>Hwang C.-Y., Hwang Y.-Y., Chen Y.-J., Chen C.-C., Lin M.-W., Chen T.-J., Lee D.-D., Chang Y.-T., Wang W.-J., Liu H.-N. Atopic diathesis in patients with Kawasaki disease. J. Pediatr. 2013;163(3):811–815.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23647775</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brosius C.L., Newburger J.W., Burns J.C., Hojnowski-diaz P., Zierler S., Leung D.Y. Increased prevalence of atopic dermatitis in Kawasaki disease. Pediatr. Infect. Dis. J. 1988;7(12):863–866.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3211629</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
